Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)
China · Delayed Price · Currency is CNY 32.27
+0.42 (1.32%)
Feb 4, 2026, 2:45 PM CST
SHA:603882 Revenue
Guangzhou Kingmed Diagnostics Group had revenue of 1.54B CNY in the quarter ending September 30, 2025, a decrease of -11.32%. This brings the company's revenue in the last twelve months to 6.11B, down -22.17% year-over-year. In the year 2024, Guangzhou Kingmed Diagnostics Group had annual revenue of 7.19B, down -15.81%.
Revenue (ttm)
6.11B
Revenue Growth
-22.17%
P/S Ratio
2.42
Revenue / Employee
586.66K
Employees
10,413
Market Cap
14.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.19B | -1.35B | -15.81% |
| Dec 31, 2023 | 8.54B | -6.94B | -44.82% |
| Dec 31, 2022 | 15.48B | 3.53B | 29.58% |
| Dec 31, 2021 | 11.94B | 3.70B | 44.88% |
| Dec 31, 2020 | 8.24B | 2.97B | 56.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| BGI Genomics | 3.71B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Joinn Laboratories(China)Co.,Ltd. | 1.67B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |